But you are not a mouse
Treatment Duration A person evaluated at Month 3 may have a very different result from someone followed for Month 6, Month 9, or Month 12
Depending on the reason, the next move might be: Resubmitting with better documentation Trying a different covered medication Completing the required lifestyle program over the next 3 to 6 months Filing a formal appeal with new clinical evidence Switching to cash-pay or manufacturer programs Pausing the GLP-1 path and addressing an underlying mental health, hormonal, or metabolic issue first Considering a different FDA-approved weight loss medication The right next step depends on your specific plan, BMI, health history, prior medication trials, and treatment goals
In clinical trials, medications such as semaglutide, liraglutide, and tirzepatide consistently produce significant weight loss
3 Reduced Liver Fat GLP-1 activity is associated with decreased fat deposition and inflammation in the liver, which may help treat fatty liver disease